Define indication, target, dose, and fractions
A comparison is meaningful only when the treatment intent, target volumes, dose, fraction schedule, systemic-therapy relationship, and expected duration are clear.
Selected pathways may include IMRT, VMAT, SBRT, SRS, and indication-specific proton therapy. The treating radiation-oncology and medical-physics teams retain all clinical decisions.
Newer equipment or a lower price does not prove that a technique is clinically preferable for an individual patient.
A comparison is meaningful only when the treatment intent, target volumes, dose, fraction schedule, systemic-therapy relationship, and expected duration are clear.
Review should cover image guidance, machine quality assurance, patient-specific checks where relevant, physics review, peer review, incident learning, interruption management, and emergency access.
Complex treatment can require nutrition, airway, skin, pain, blood-count, hydration, and admission support. The home team needs a complete dose and DICOM treatment record.
Protons may reduce dose to selected normal tissues, but are not automatically more effective than modern photon therapy. Comparative benefit, uncertainty, travel burden, and full cost must be reviewed.
A current written plan and estimate are required before a cost or travel decision.